Sengenics Launches Sequenom’s New Non-Invasive Prenatal VisibiliT Test in Three Additional Territories in Asia

other

▤ Summary

The test utilizes a maternal blood sample to analyze chromosomal material in cell-free foetal DNA of pregnant women.This test will offer peace of mind for the two most common trisomies,” said Dr Arif Anwar, Technical Director of Sengenics.VisibiliT will be made available through Sengenics’ select panel of partner O&G Clinicians and Hospitals in Singapore, Indonesia, Thailand, Malaysia and Brunei.Biopolis, Singapore, September 02, 2014 --( PR.com )-- Sengenics, a leading molecular diagnostics and research company in the region, today announced the launch of VisibiliT, Sequenoms new low-cost, non-invasive, prenatal test.The test utilizes a maternal blood sample to analyze chromosomal material in cell-free foetal DNA of pregnant women.

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies